US small-cap stocks have historically performed well in the months following US presidential elections, regardless of the ...

Which is just a comment that the proposed CFPB rule isn’t just wrongheaded, it’s also insulting to banks and to reason itself ...

In this article, we will take a look into The Goldman Sachs Group Inc's (NYSE:GS) DCF analysis, a reliable and data-driven ...

While some analysts see a pause in the Fed's rate cutting cycle, Apollo's chief economist thinks the Fed could shock markets ...

The Federal Reserve is likely to signal a slower future pace of easing when it meets later this week and then skip cutting ...

Emerging Asian governments are set to boost bond issuance by as much as 68% next year as they refinance Covid-era debt, ...

Donald Trump and Mohammed bin Salman each have contradictory objectives in 2025. The U.S. president-elect wants to apply ...

Chinese leaders are discussing the possibility of letting their currency weaken to blunt the impact of potential U.S. trade ...

A $25M retail center is almost ready to join a busy shopping area, Baltimore County accounting firms plan to merge and more ...

High mortgage rates and home prices have kept many Americans in place—and upgrading their homes. Experts say that could ...

Pharmaceutical and biotech stocks often are seen as steady and safe options for investors for one particular reason.

Fintel reports that on December 16, 2024, Goldman Sachs upgraded their outlook for LifeStance Health Group (NasdaqGS:LFST) ...